Research presented today at the 2007 Annual Meeting of the American Association for Cancer Research confirmed that there is now an effective treatment option for colorectal cancer patients for whom all other treatment options have been exhausted — cetuximab.
A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
An international research team ? including investigators from Massachusetts General Hospital (MGH) and the Broad Institute of Harvard University and Massachusetts Institute of Technology ? has identified several novel genetic variations associated with the risk of Crohn’s disease.
Genetic variations in the body’s immune system could play a role in making African Americans more susceptible to developing colon cancer, scientists have found.
A study conducted by researchers at Fred Hutchinson Cancer Research Center to see how stress – reduction workshops can help women with a family history of breast cancer manage their everyday stresses and cancer-risk concerns.
Researchers at the University of Colorado at Denver and Health Sciences Center have found that nitric oxide plays an important role in tumor cell survival following treatment with radiation therapy.
Immune cells that are the body?s front-line defense don?t necessarily rest quietly until invading bacteria lock onto receptors on their outside skins and rouse them to action, as previously thought.
An international consortium of scientists has completed a draft sequence of the genome of the rhesus macaque, a species of non-human primate that is widely used for creating models of human diseases and infections.
For the growing number of people with diminished immune systems — cancer patients, transplant recipients, those with HIV/AIDS — infection by a ubiquitous mold known as Aspergillus fumigatus can be a death sentence.
Developing brain tumors can coax assistance from nearby cells known as microglia, according to a new study from scientists at Washington University School of Medicine in St. Louis. The researchers have identified one protein made by microglia that helps accelerate tumor growth and are looking for others.